GENETICS OF NK CELL RECEPTORS AND HLA LIGANDS

NK 细胞受体和 HLA 配体的遗传学

• 批准号: 8245885
• 负责人: Bo Dupont
• 金额: $ 27.44万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-09-01 至 2013-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8245885
• 关键词: Alleles; Allografting; Area; CD94 Antigen; Cell Line; Clinical; Complementary DNA; Genes; Genetic; Genomics; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens; Histocompatibility Antigens Class I; Histocompatibility Testing; Human; Immunobiology; Killer Cells; Laboratories; Ligands; MHC Class II Genes; Malignant Neoplasms; Marrow; Monitor; Outcome; Patients; Research Personnel; Resolution; Testing; Transplantation; improved; killer inhibitory receptor; leukemia; programs; research and development; volunteer

by this Core will continue to facilitate the research and development in the area of hematopoietic stem cell transplantation. The Core activities will accelerate the translational applications in the proposed trials and help improve the outcome in patients undergoing transplantation for a number of malignancies.

通过这个核心将继续 促进造血干细胞移植区域的研究和发展。核心 活动将加速拟议试验中的翻译应用，并有助于改善 许多恶性肿瘤接受移植的患者的结果。